Loading…
Anatoxin-a is a potent agonist of the nicotinic acetylcholine receptor of bovine adrenal chromaffin cells
(+)-Anatoxin-a is a neurotoxic alkaloid produced by the cyanobacterium Anabaena flos-aquae. In this study synthetic (±)-anatoxin-a was tested on isolated bovine adrenal chromaffin cells to determine its ability to evoke secretion of endogenous catecholamines through neuronal-type nicotinic receptor...
Saved in:
Published in: | European journal of pharmacology 1995-05, Vol.289 (3), p.447-453 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c417t-d6e38498e88ddf2f771e99fc4f2590e0000f34419e216db23383ba694459d6823 |
---|---|
cites | cdi_FETCH-LOGICAL-c417t-d6e38498e88ddf2f771e99fc4f2590e0000f34419e216db23383ba694459d6823 |
container_end_page | 453 |
container_issue | 3 |
container_start_page | 447 |
container_title | European journal of pharmacology |
container_volume | 289 |
creator | Molloy, Leah Wonnacott, Susan Gallagher, Timothy Brough, Paul A. Livett, Bruce G. |
description | (+)-Anatoxin-a is a neurotoxic alkaloid produced by the cyanobacterium
Anabaena flos-aquae. In this study synthetic (±)-anatoxin-a was tested on isolated bovine adrenal chromaffin cells to determine its ability to evoke secretion of endogenous catecholamines through neuronal-type nicotinic receptor activation. Anatoxin-a was found to act as a potent agonist of the secretory response of chromaffin cells with an EC
50 of 1–2 μM, compared with an EC
50 of 4–5 μM for nicotine. The cells responded to anatoxin-a and nicotine with bell-shaped concentration-response curves consistent with desensitisation at concentrations of anatoxin-a greater than 5 μM and of nicotine greater than 20 μM. The secretion of catecholamines stimulated by anatoxin-a was completely inhibited in a non-competitive manner by the nicotinic antagonist mecamylamine with an IC
50 of 0.4–0.5 μM. In the presence of depolarising concentrations of K
+ (15 or 50 mM), anatoxin-a increased the secretion of catecholamines in a concentration-dependent manner up to the same maximum as that achieved by anatoxin-a alone. It is concluded that anatoxin-a acts as a potent and selective nicotinic agonist, capable of evoking secretion of endogenous catecholamines from chromaffin cells via their neuronal-type nicotinic receptor. |
doi_str_mv | 10.1016/0922-4106(95)90153-1 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_15597816</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0922410695901531</els_id><sourcerecordid>15597816</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-d6e38498e88ddf2f771e99fc4f2590e0000f34419e216db23383ba694459d6823</originalsourceid><addsrcrecordid>eNp9kEtPAyEQgDlotD7-gSYcjNHDKiywu1xMTOMrMfGiZ0JhsJgtVKBG_727tunRy0wy880wfAidUHJFCW2uiazrilPSXEhxKQkVrKI7aLIt76ODnD8IIZJKvof2WiEaTtkE-dugS_z2odLYZ6zxMhYIBev3GHwuODpc5oCDN7H4IWJtoPz0Zh57HwAnMLAsMY3cLH6NJW0TBN1jM09xoZ3zARvo-3yEdp3uMxxv8iF6u797nT5Wzy8PT9Pb58pw2pbKNsA6LjvoOmtd7dqWgpTOcFcLSWD4AnGMcyqhpo2d1Yx1bKYbybmQtulqdojO13uXKX6uIBe18Hm8QAeIq6yoELLtaDOAfA2aFHNO4NQy-YVOP4oSNVpVoz416lNSqD-rig5jp5v9q9kC7HZoo3Ton236Ohvdu6SD8XmLsfF5QQbsZo3B4OLLQ1LZeAgGrB-kFmWj__-OX6aylVY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15597816</pqid></control><display><type>article</type><title>Anatoxin-a is a potent agonist of the nicotinic acetylcholine receptor of bovine adrenal chromaffin cells</title><source>ScienceDirect Freedom Collection</source><creator>Molloy, Leah ; Wonnacott, Susan ; Gallagher, Timothy ; Brough, Paul A. ; Livett, Bruce G.</creator><creatorcontrib>Molloy, Leah ; Wonnacott, Susan ; Gallagher, Timothy ; Brough, Paul A. ; Livett, Bruce G.</creatorcontrib><description>(+)-Anatoxin-a is a neurotoxic alkaloid produced by the cyanobacterium
Anabaena flos-aquae. In this study synthetic (±)-anatoxin-a was tested on isolated bovine adrenal chromaffin cells to determine its ability to evoke secretion of endogenous catecholamines through neuronal-type nicotinic receptor activation. Anatoxin-a was found to act as a potent agonist of the secretory response of chromaffin cells with an EC
50 of 1–2 μM, compared with an EC
50 of 4–5 μM for nicotine. The cells responded to anatoxin-a and nicotine with bell-shaped concentration-response curves consistent with desensitisation at concentrations of anatoxin-a greater than 5 μM and of nicotine greater than 20 μM. The secretion of catecholamines stimulated by anatoxin-a was completely inhibited in a non-competitive manner by the nicotinic antagonist mecamylamine with an IC
50 of 0.4–0.5 μM. In the presence of depolarising concentrations of K
+ (15 or 50 mM), anatoxin-a increased the secretion of catecholamines in a concentration-dependent manner up to the same maximum as that achieved by anatoxin-a alone. It is concluded that anatoxin-a acts as a potent and selective nicotinic agonist, capable of evoking secretion of endogenous catecholamines from chromaffin cells via their neuronal-type nicotinic receptor.</description><identifier>ISSN: 0922-4106</identifier><identifier>ISSN: 0014-2999</identifier><identifier>DOI: 10.1016/0922-4106(95)90153-1</identifier><identifier>PMID: 7556413</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adrenaline release ; Anabaena flos-aquae ; Anatoxin-a ; Animals ; Bacterial Toxins - antagonists & inhibitors ; Bacterial Toxins - pharmacology ; Biological and medical sciences ; Cattle ; Cells, Cultured ; Cholinergic system ; Chromaffin cell ; Chromaffin System - cytology ; Chromaffin System - drug effects ; Chromaffin System - metabolism ; Cyanophyta ; Epinephrine - metabolism ; Marine Toxins - antagonists & inhibitors ; Marine Toxins - pharmacology ; Mecamylamine ; Mecamylamine - pharmacology ; Medical sciences ; Microcystins ; Neuropharmacology ; Neurotoxins - antagonists & inhibitors ; Neurotoxins - pharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Nicotine - pharmacology ; Nicotinic acetylcholine receptor, neuronal type ; Nicotinic Agonists - pharmacology ; Nicotinic receptor agonist ; Noradrenaline release ; Norepinephrine - metabolism ; Pharmacology. Drug treatments ; Potassium - pharmacology ; Tropanes</subject><ispartof>European journal of pharmacology, 1995-05, Vol.289 (3), p.447-453</ispartof><rights>1995</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-d6e38498e88ddf2f771e99fc4f2590e0000f34419e216db23383ba694459d6823</citedby><cites>FETCH-LOGICAL-c417t-d6e38498e88ddf2f771e99fc4f2590e0000f34419e216db23383ba694459d6823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3559750$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7556413$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Molloy, Leah</creatorcontrib><creatorcontrib>Wonnacott, Susan</creatorcontrib><creatorcontrib>Gallagher, Timothy</creatorcontrib><creatorcontrib>Brough, Paul A.</creatorcontrib><creatorcontrib>Livett, Bruce G.</creatorcontrib><title>Anatoxin-a is a potent agonist of the nicotinic acetylcholine receptor of bovine adrenal chromaffin cells</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>(+)-Anatoxin-a is a neurotoxic alkaloid produced by the cyanobacterium
Anabaena flos-aquae. In this study synthetic (±)-anatoxin-a was tested on isolated bovine adrenal chromaffin cells to determine its ability to evoke secretion of endogenous catecholamines through neuronal-type nicotinic receptor activation. Anatoxin-a was found to act as a potent agonist of the secretory response of chromaffin cells with an EC
50 of 1–2 μM, compared with an EC
50 of 4–5 μM for nicotine. The cells responded to anatoxin-a and nicotine with bell-shaped concentration-response curves consistent with desensitisation at concentrations of anatoxin-a greater than 5 μM and of nicotine greater than 20 μM. The secretion of catecholamines stimulated by anatoxin-a was completely inhibited in a non-competitive manner by the nicotinic antagonist mecamylamine with an IC
50 of 0.4–0.5 μM. In the presence of depolarising concentrations of K
+ (15 or 50 mM), anatoxin-a increased the secretion of catecholamines in a concentration-dependent manner up to the same maximum as that achieved by anatoxin-a alone. It is concluded that anatoxin-a acts as a potent and selective nicotinic agonist, capable of evoking secretion of endogenous catecholamines from chromaffin cells via their neuronal-type nicotinic receptor.</description><subject>Adrenaline release</subject><subject>Anabaena flos-aquae</subject><subject>Anatoxin-a</subject><subject>Animals</subject><subject>Bacterial Toxins - antagonists & inhibitors</subject><subject>Bacterial Toxins - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cattle</subject><subject>Cells, Cultured</subject><subject>Cholinergic system</subject><subject>Chromaffin cell</subject><subject>Chromaffin System - cytology</subject><subject>Chromaffin System - drug effects</subject><subject>Chromaffin System - metabolism</subject><subject>Cyanophyta</subject><subject>Epinephrine - metabolism</subject><subject>Marine Toxins - antagonists & inhibitors</subject><subject>Marine Toxins - pharmacology</subject><subject>Mecamylamine</subject><subject>Mecamylamine - pharmacology</subject><subject>Medical sciences</subject><subject>Microcystins</subject><subject>Neuropharmacology</subject><subject>Neurotoxins - antagonists & inhibitors</subject><subject>Neurotoxins - pharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Nicotine - pharmacology</subject><subject>Nicotinic acetylcholine receptor, neuronal type</subject><subject>Nicotinic Agonists - pharmacology</subject><subject>Nicotinic receptor agonist</subject><subject>Noradrenaline release</subject><subject>Norepinephrine - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Potassium - pharmacology</subject><subject>Tropanes</subject><issn>0922-4106</issn><issn>0014-2999</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNp9kEtPAyEQgDlotD7-gSYcjNHDKiywu1xMTOMrMfGiZ0JhsJgtVKBG_727tunRy0wy880wfAidUHJFCW2uiazrilPSXEhxKQkVrKI7aLIt76ODnD8IIZJKvof2WiEaTtkE-dugS_z2odLYZ6zxMhYIBev3GHwuODpc5oCDN7H4IWJtoPz0Zh57HwAnMLAsMY3cLH6NJW0TBN1jM09xoZ3zARvo-3yEdp3uMxxv8iF6u797nT5Wzy8PT9Pb58pw2pbKNsA6LjvoOmtd7dqWgpTOcFcLSWD4AnGMcyqhpo2d1Yx1bKYbybmQtulqdojO13uXKX6uIBe18Hm8QAeIq6yoELLtaDOAfA2aFHNO4NQy-YVOP4oSNVpVoz416lNSqD-rig5jp5v9q9kC7HZoo3Ton236Ohvdu6SD8XmLsfF5QQbsZo3B4OLLQ1LZeAgGrB-kFmWj__-OX6aylVY</recordid><startdate>19950526</startdate><enddate>19950526</enddate><creator>Molloy, Leah</creator><creator>Wonnacott, Susan</creator><creator>Gallagher, Timothy</creator><creator>Brough, Paul A.</creator><creator>Livett, Bruce G.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>F1W</scope><scope>FR3</scope><scope>H99</scope><scope>L.F</scope><scope>L.G</scope><scope>P64</scope></search><sort><creationdate>19950526</creationdate><title>Anatoxin-a is a potent agonist of the nicotinic acetylcholine receptor of bovine adrenal chromaffin cells</title><author>Molloy, Leah ; Wonnacott, Susan ; Gallagher, Timothy ; Brough, Paul A. ; Livett, Bruce G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-d6e38498e88ddf2f771e99fc4f2590e0000f34419e216db23383ba694459d6823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adrenaline release</topic><topic>Anabaena flos-aquae</topic><topic>Anatoxin-a</topic><topic>Animals</topic><topic>Bacterial Toxins - antagonists & inhibitors</topic><topic>Bacterial Toxins - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cattle</topic><topic>Cells, Cultured</topic><topic>Cholinergic system</topic><topic>Chromaffin cell</topic><topic>Chromaffin System - cytology</topic><topic>Chromaffin System - drug effects</topic><topic>Chromaffin System - metabolism</topic><topic>Cyanophyta</topic><topic>Epinephrine - metabolism</topic><topic>Marine Toxins - antagonists & inhibitors</topic><topic>Marine Toxins - pharmacology</topic><topic>Mecamylamine</topic><topic>Mecamylamine - pharmacology</topic><topic>Medical sciences</topic><topic>Microcystins</topic><topic>Neuropharmacology</topic><topic>Neurotoxins - antagonists & inhibitors</topic><topic>Neurotoxins - pharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Nicotine - pharmacology</topic><topic>Nicotinic acetylcholine receptor, neuronal type</topic><topic>Nicotinic Agonists - pharmacology</topic><topic>Nicotinic receptor agonist</topic><topic>Noradrenaline release</topic><topic>Norepinephrine - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Potassium - pharmacology</topic><topic>Tropanes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Molloy, Leah</creatorcontrib><creatorcontrib>Wonnacott, Susan</creatorcontrib><creatorcontrib>Gallagher, Timothy</creatorcontrib><creatorcontrib>Brough, Paul A.</creatorcontrib><creatorcontrib>Livett, Bruce G.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Engineering Research Database</collection><collection>ASFA: Marine Biotechnology Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Marine Biotechnology Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Molloy, Leah</au><au>Wonnacott, Susan</au><au>Gallagher, Timothy</au><au>Brough, Paul A.</au><au>Livett, Bruce G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anatoxin-a is a potent agonist of the nicotinic acetylcholine receptor of bovine adrenal chromaffin cells</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>1995-05-26</date><risdate>1995</risdate><volume>289</volume><issue>3</issue><spage>447</spage><epage>453</epage><pages>447-453</pages><issn>0922-4106</issn><issn>0014-2999</issn><abstract>(+)-Anatoxin-a is a neurotoxic alkaloid produced by the cyanobacterium
Anabaena flos-aquae. In this study synthetic (±)-anatoxin-a was tested on isolated bovine adrenal chromaffin cells to determine its ability to evoke secretion of endogenous catecholamines through neuronal-type nicotinic receptor activation. Anatoxin-a was found to act as a potent agonist of the secretory response of chromaffin cells with an EC
50 of 1–2 μM, compared with an EC
50 of 4–5 μM for nicotine. The cells responded to anatoxin-a and nicotine with bell-shaped concentration-response curves consistent with desensitisation at concentrations of anatoxin-a greater than 5 μM and of nicotine greater than 20 μM. The secretion of catecholamines stimulated by anatoxin-a was completely inhibited in a non-competitive manner by the nicotinic antagonist mecamylamine with an IC
50 of 0.4–0.5 μM. In the presence of depolarising concentrations of K
+ (15 or 50 mM), anatoxin-a increased the secretion of catecholamines in a concentration-dependent manner up to the same maximum as that achieved by anatoxin-a alone. It is concluded that anatoxin-a acts as a potent and selective nicotinic agonist, capable of evoking secretion of endogenous catecholamines from chromaffin cells via their neuronal-type nicotinic receptor.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>7556413</pmid><doi>10.1016/0922-4106(95)90153-1</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0922-4106 |
ispartof | European journal of pharmacology, 1995-05, Vol.289 (3), p.447-453 |
issn | 0922-4106 0014-2999 |
language | eng |
recordid | cdi_proquest_miscellaneous_15597816 |
source | ScienceDirect Freedom Collection |
subjects | Adrenaline release Anabaena flos-aquae Anatoxin-a Animals Bacterial Toxins - antagonists & inhibitors Bacterial Toxins - pharmacology Biological and medical sciences Cattle Cells, Cultured Cholinergic system Chromaffin cell Chromaffin System - cytology Chromaffin System - drug effects Chromaffin System - metabolism Cyanophyta Epinephrine - metabolism Marine Toxins - antagonists & inhibitors Marine Toxins - pharmacology Mecamylamine Mecamylamine - pharmacology Medical sciences Microcystins Neuropharmacology Neurotoxins - antagonists & inhibitors Neurotoxins - pharmacology Neurotransmitters. Neurotransmission. Receptors Nicotine - pharmacology Nicotinic acetylcholine receptor, neuronal type Nicotinic Agonists - pharmacology Nicotinic receptor agonist Noradrenaline release Norepinephrine - metabolism Pharmacology. Drug treatments Potassium - pharmacology Tropanes |
title | Anatoxin-a is a potent agonist of the nicotinic acetylcholine receptor of bovine adrenal chromaffin cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A31%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anatoxin-a%20is%20a%20potent%20agonist%20of%20the%20nicotinic%20acetylcholine%20receptor%20of%20bovine%20adrenal%20chromaffin%20cells&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Molloy,%20Leah&rft.date=1995-05-26&rft.volume=289&rft.issue=3&rft.spage=447&rft.epage=453&rft.pages=447-453&rft.issn=0922-4106&rft_id=info:doi/10.1016/0922-4106(95)90153-1&rft_dat=%3Cproquest_cross%3E15597816%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c417t-d6e38498e88ddf2f771e99fc4f2590e0000f34419e216db23383ba694459d6823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=15597816&rft_id=info:pmid/7556413&rfr_iscdi=true |